Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,903.50 -9.50 (-0.50%)

Bid:

1,904.00

Ask:

1,905.00

Spread: 1.00 (0.053%)

Market Cap: £76.34b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

LONDON BRIEFING: GSK, Aston Martin back outlook; Next raises view

(Alliance News) - Stocks in London are set to open in the red on Wednesday, ahead of the eagerly-anticipated UK government budget announcement and a b...

GSK maintains guidance after mixed third quarter

(Sharecast News) - GSK reported a mixed third-quarter performance on Wednesday, with a notable boost from specialty medicines helping to offset weaker...

GSK inks deal to buy lupus therapy from Chimagen for USD300 million

(Alliance News) - GSK PLC on Tuesday said that it has signed a deal to buy CMG1A46 from Chimagen Biosciences for USD300 million upfront.

IN BRIEF: GSK says Arexvy vaccine tests show wider potential for RSV

GSK PLC - London-based pharmaceutical and biotechnology - Tests of Arexvy, GSK's vaccine against respiratory syncytial virus, shows it can protect a w...

GSK RSV vaccine shows potential to help protect broader group of adults

(Sharecast News) - Drugmaker GSK said on Thursday that new data for its respiratory syncytial virus vaccine showed potential to help protect a broader...

UK earnings, trading statements calendar - next 7 days

LONDON MARKET OPEN: Stocks stay green as UK CPI print boosts sentiment

(Alliance News) - Stock prices in London opened higher on Wednesday morning, following a strong CPI print for September, which showed that UK consumer...

GSK's application for urinary tract infections drug is accepted

(Alliance News) - GSK PLC on Wednesday announced that the US Food & Drug Administration has accepted its New Drug Application for gepotidacin.